Cresco Labs has launched a new edibles brand, Sunnyside Chews, available only in Florida.
The company is also introducing products under its Supply, Good News and Remedi brands. Cresco Labs will soon expand to Florida its premium craft-quality flower brand, FloraCal Farms, and bestselling flagship brand, Cresco.
“We’ve demonstrated our ability to reach leading market share positions in large medical markets based on the strength of our products and the value we provide patients,” said Charlie Bachtell, CEO and co-founder of Cresco Labs. “We’re proud to offer those popular brands to Florida patients for the first time. We’re relentlessly focused on quality, consistency and availability, and we’ll keep that promise to patients as we continue to scale in the state.”
Throughout March, Florida patients can expect Cresco Labs’ branded products to be available for sale exclusively at the company’s 15 Sunnyside locations.
Nuances of OMMU regulations created an opportunity for Cresco to develop the Florida market’s first effect-driven gummy under a new brand, Sunnyside Chews. Using a proprietary blend of distillate oil and live rosin terpenes with no additives or fillers, Sunnyside Chews are precisely dosed for consistent cannabis experiences and deliver 10 mg THC per Chew. The product lineup is gluten free and features four flavors and effects: Watermelon (Sativa), Sour Pineapple (Sativa), Orange (Hybrid), and Blue Raspberry (Indica). Each pouch includes 10 Chews and 100 mg THC.
Customers will also find Supply cartridges, Good News vape pens and Remedi tincture, balm and RSO syringe.
Stephanie Gorecki, VP of product development for Cresco Labs, will deliver a keynote presentation on applying traditional R&D methodologies to cannabis product development during Cannabis Products Exchange, set for April 28-29 in Denver. Visit the CPX website to learn more and register.